Finally, we investigated the aggregate concentration of MCP-1 in all brain regions of female and male TBI donors presenting both with and without dementia to evaluate the potential of MCP-1 to serve as a biomarker for the progression of a dementia cascade following TBI. Here, CCL2 is linked to dementia.